Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | -2.10% | +6.06% | -28.93% |
05-13 | Ikena Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-12 | Ikena Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.93% | 69.01M | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- IKNA Stock
- News Ikena Oncology, Inc.
- Ikena Oncology Completes Acquisition of Pionyr Immunotherapeutics in All-Stock Deal